ClinicalTrials.govpublic full text
A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection
hepatitis c, chronic, genotype 2, genotype 3, telaprevir, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 829216
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.